nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—DRD1—bipolar disorder	0.33	0.417	CbGaD
Methylergometrine—HTR2C—bipolar disorder	0.283	0.356	CbGaD
Methylergometrine—HTR2A—bipolar disorder	0.18	0.227	CbGaD
Methylergometrine—DRD1—telencephalic ventricle—bipolar disorder	0.00803	0.153	CbGeAlD
Methylergometrine—HTR2A—locus ceruleus—bipolar disorder	0.0066	0.126	CbGeAlD
Methylergometrine—HTR2C—telencephalic ventricle—bipolar disorder	0.00624	0.119	CbGeAlD
Methylergometrine—HTR2A—autonomic nervous system—bipolar disorder	0.00351	0.067	CbGeAlD
Methylergometrine—HTR2A—telencephalic ventricle—bipolar disorder	0.00313	0.0598	CbGeAlD
Methylergometrine—HTR2A—urine—bipolar disorder	0.00286	0.0546	CbGeAlD
Methylergometrine—CYP3A4—urine—bipolar disorder	0.00265	0.0506	CbGeAlD
Methylergometrine—HTR1F—nervous system—bipolar disorder	0.00225	0.043	CbGeAlD
Methylergometrine—HTR1E—nervous system—bipolar disorder	0.00195	0.0373	CbGeAlD
Methylergometrine—HTR1F—brain—bipolar disorder	0.00172	0.0329	CbGeAlD
Methylergometrine—HTR2A—blood plasma—bipolar disorder	0.00149	0.0285	CbGeAlD
Methylergometrine—HTR1E—brain—bipolar disorder	0.00149	0.0285	CbGeAlD
Methylergometrine—HTR2B—adrenal cortex—bipolar disorder	0.00142	0.0271	CbGeAlD
Methylergometrine—CYP3A4—blood plasma—bipolar disorder	0.00138	0.0264	CbGeAlD
Methylergometrine—DRD1—nervous system—bipolar disorder	0.00114	0.0218	CbGeAlD
Methylergometrine—HTR2B—thyroid gland—bipolar disorder	0.000987	0.0189	CbGeAlD
Methylergometrine—HTR2C—nervous system—bipolar disorder	0.000884	0.0169	CbGeAlD
Methylergometrine—DRD1—brain—bipolar disorder	0.00087	0.0166	CbGeAlD
Methylergometrine—HTR2B—nervous system—bipolar disorder	0.000831	0.0159	CbGeAlD
Methylergometrine—Pergolide—DRD5—bipolar disorder	0.000764	0.0805	CrCbGaD
Methylergometrine—HTR2C—brain—bipolar disorder	0.000676	0.0129	CbGeAlD
Methylergometrine—Lisuride—DRD5—bipolar disorder	0.000663	0.0699	CrCbGaD
Methylergometrine—HTR2B—brain—bipolar disorder	0.000635	0.0121	CbGeAlD
Methylergometrine—Bromocriptine—DRD5—bipolar disorder	0.000614	0.0647	CrCbGaD
Methylergometrine—HTR2A—nervous system—bipolar disorder	0.000443	0.00848	CbGeAlD
Methylergometrine—Ergonovine—HTR2C—bipolar disorder	0.000419	0.0441	CrCbGaD
Methylergometrine—HTR2A—cerebellum—bipolar disorder	0.000417	0.00798	CbGeAlD
Methylergometrine—CYP3A4—nervous system—bipolar disorder	0.000411	0.00785	CbGeAlD
Methylergometrine—Pergolide—DRD4—bipolar disorder	0.000391	0.0412	CrCbGaD
Methylergometrine—Lisuride—DRD4—bipolar disorder	0.000339	0.0357	CrCbGaD
Methylergometrine—HTR2A—brain—bipolar disorder	0.000339	0.00648	CbGeAlD
Methylergometrine—Pergolide—DRD3—bipolar disorder	0.000337	0.0355	CrCbGaD
Methylergometrine—Pergolide—DRD1—bipolar disorder	0.000331	0.0349	CrCbGaD
Methylergometrine—Bromocriptine—DRD4—bipolar disorder	0.000314	0.0331	CrCbGaD
Methylergometrine—Methysergide—HTR2C—bipolar disorder	0.000306	0.0322	CrCbGaD
Methylergometrine—Methysergide—HTR1A—bipolar disorder	0.000297	0.0313	CrCbGaD
Methylergometrine—Lisuride—DRD3—bipolar disorder	0.000292	0.0308	CrCbGaD
Methylergometrine—Lisuride—DRD1—bipolar disorder	0.000287	0.0303	CrCbGaD
Methylergometrine—Pergolide—HTR2C—bipolar disorder	0.000283	0.0298	CrCbGaD
Methylergometrine—Pergolide—HTR1A—bipolar disorder	0.000275	0.0289	CrCbGaD
Methylergometrine—Bromocriptine—DRD3—bipolar disorder	0.000271	0.0286	CrCbGaD
Methylergometrine—Bromocriptine—DRD1—bipolar disorder	0.000266	0.028	CrCbGaD
Methylergometrine—Lisuride—HTR2C—bipolar disorder	0.000246	0.0259	CrCbGaD
Methylergometrine—Lisuride—HTR1A—bipolar disorder	0.000238	0.0251	CrCbGaD
Methylergometrine—Ergotamine—HTR2C—bipolar disorder	0.000236	0.0249	CrCbGaD
Methylergometrine—Pergolide—DRD2—bipolar disorder	0.000233	0.0246	CrCbGaD
Methylergometrine—Ergotamine—HTR1A—bipolar disorder	0.000229	0.0241	CrCbGaD
Methylergometrine—Bromocriptine—HTR2C—bipolar disorder	0.000228	0.024	CrCbGaD
Methylergometrine—Bromocriptine—HTR1A—bipolar disorder	0.000221	0.0233	CrCbGaD
Methylergometrine—Lisuride—DRD2—bipolar disorder	0.000202	0.0213	CrCbGaD
Methylergometrine—Methysergide—HTR2A—bipolar disorder	0.000195	0.0205	CrCbGaD
Methylergometrine—Ergotamine—DRD2—bipolar disorder	0.000194	0.0205	CrCbGaD
Methylergometrine—Bromocriptine—DRD2—bipolar disorder	0.000188	0.0198	CrCbGaD
Methylergometrine—Pergolide—HTR2A—bipolar disorder	0.00018	0.019	CrCbGaD
Methylergometrine—Lisuride—HTR2A—bipolar disorder	0.000156	0.0165	CrCbGaD
Methylergometrine—Ergotamine—HTR2A—bipolar disorder	0.00015	0.0158	CrCbGaD
Methylergometrine—Bromocriptine—HTR2A—bipolar disorder	0.000145	0.0153	CrCbGaD
Methylergometrine—HTR2B—GPCR downstream signaling—DRD4—bipolar disorder	3.9e-05	0.000268	CbGpPWpGaD
Methylergometrine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	3.9e-05	0.000268	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—RGS4—bipolar disorder	3.87e-05	0.000266	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TAC1—bipolar disorder	3.86e-05	0.000265	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—TAC1—bipolar disorder	3.84e-05	0.000264	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	3.81e-05	0.000262	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—PDE4B—bipolar disorder	3.8e-05	0.000261	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—TSHB—bipolar disorder	3.8e-05	0.000261	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—TACR1—bipolar disorder	3.8e-05	0.000261	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—DRD3—bipolar disorder	3.79e-05	0.00026	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AKR1C4—bipolar disorder	3.79e-05	0.00026	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—DRD1—bipolar disorder	3.78e-05	0.00026	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—HTR2C—bipolar disorder	3.78e-05	0.00026	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—DRD1—bipolar disorder	3.77e-05	0.000259	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—HTR2C—bipolar disorder	3.77e-05	0.000259	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—ADM—bipolar disorder	3.73e-05	0.000256	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—DRD5—bipolar disorder	3.73e-05	0.000256	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—HTR2A—bipolar disorder	3.71e-05	0.000254	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—HTR1A—bipolar disorder	3.7e-05	0.000254	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NTRK2—bipolar disorder	3.68e-05	0.000253	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—HTR1A—bipolar disorder	3.68e-05	0.000253	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—DRD4—bipolar disorder	3.68e-05	0.000253	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—ADCY2—bipolar disorder	3.67e-05	0.000252	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—DRD3—bipolar disorder	3.66e-05	0.000252	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—RGS4—bipolar disorder	3.65e-05	0.000251	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—DRD3—bipolar disorder	3.65e-05	0.000251	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—GSK3A—bipolar disorder	3.65e-05	0.000251	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TAC1—bipolar disorder	3.64e-05	0.00025	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—TSHB—bipolar disorder	3.64e-05	0.00025	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—PDE4B—bipolar disorder	3.64e-05	0.00025	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—TACR1—bipolar disorder	3.64e-05	0.00025	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—DRD2—bipolar disorder	3.63e-05	0.00025	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—HTR2A—bipolar disorder	3.63e-05	0.000249	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—TAC1—bipolar disorder	3.62e-05	0.000249	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—POMC—bipolar disorder	3.6e-05	0.000247	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—HTR2C—bipolar disorder	3.57e-05	0.000245	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—DRD1—bipolar disorder	3.57e-05	0.000245	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—DRD4—bipolar disorder	3.56e-05	0.000244	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—HTR2C—bipolar disorder	3.55e-05	0.000244	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—TRPC3—bipolar disorder	3.55e-05	0.000244	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—DRD4—bipolar disorder	3.54e-05	0.000243	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—DGKH—bipolar disorder	3.48e-05	0.000239	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NTRK2—bipolar disorder	3.47e-05	0.000238	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—HTR1A—bipolar disorder	3.47e-05	0.000238	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—ADCY2—bipolar disorder	3.46e-05	0.000238	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—DRD3—bipolar disorder	3.46e-05	0.000237	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—POMC—bipolar disorder	3.45e-05	0.000237	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—GSK3A—bipolar disorder	3.44e-05	0.000236	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—DRD3—bipolar disorder	3.44e-05	0.000236	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—DRD2—bipolar disorder	3.43e-05	0.000235	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—TAC1—bipolar disorder	3.41e-05	0.000234	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—POMC—bipolar disorder	3.39e-05	0.000233	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—ADM—bipolar disorder	3.39e-05	0.000233	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—DRD4—bipolar disorder	3.36e-05	0.00023	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—ADCY2—bipolar disorder	3.35e-05	0.00023	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—DRD1—bipolar disorder	3.35e-05	0.00023	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—DRD4—bipolar disorder	3.34e-05	0.000229	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TCF7L2—bipolar disorder	3.34e-05	0.000229	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—ADCY2—bipolar disorder	3.33e-05	0.000229	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—DRD2—bipolar disorder	3.31e-05	0.000228	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	3.31e-05	0.000227	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—TSHB—bipolar disorder	3.3e-05	0.000227	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PDE4B—bipolar disorder	3.3e-05	0.000227	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—TACR1—bipolar disorder	3.3e-05	0.000227	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—DRD2—bipolar disorder	3.3e-05	0.000227	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AKR1C4—bipolar disorder	3.29e-05	0.000226	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—POMC—bipolar disorder	3.26e-05	0.000224	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—DRD3—bipolar disorder	3.24e-05	0.000223	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—COMT—bipolar disorder	3.2e-05	0.00022	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—DRD5—bipolar disorder	3.19e-05	0.000219	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—MAOA—bipolar disorder	3.18e-05	0.000218	CbGpPWpGaD
Methylergometrine—CYP3A4—Metapathway biotransformation—COMT—bipolar disorder	3.16e-05	0.000217	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—ADCY2—bipolar disorder	3.16e-05	0.000217	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TCF7L2—bipolar disorder	3.15e-05	0.000216	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—HTR1A—bipolar disorder	3.15e-05	0.000216	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—DRD4—bipolar disorder	3.15e-05	0.000216	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—ADCY2—bipolar disorder	3.14e-05	0.000216	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—POMC—bipolar disorder	3.14e-05	0.000215	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RGS4—bipolar disorder	3.13e-05	0.000215	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—DRD2—bipolar disorder	3.13e-05	0.000215	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—DRD2—bipolar disorder	3.11e-05	0.000214	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—TAC1—bipolar disorder	3.1e-05	0.000213	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—DRD1—bipolar disorder	3.04e-05	0.000209	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DGKH—bipolar disorder	3.03e-05	0.000208	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—HTR1A—bipolar disorder	3.01e-05	0.000207	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NTRK1—bipolar disorder	3e-05	0.000206	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TRPC3—bipolar disorder	2.99e-05	0.000206	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—TAC1—bipolar disorder	2.96e-05	0.000204	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—ADCY2—bipolar disorder	2.96e-05	0.000203	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—POMC—bipolar disorder	2.96e-05	0.000203	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—DRD3—bipolar disorder	2.94e-05	0.000202	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—DRD2—bipolar disorder	2.93e-05	0.000201	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—S100B—bipolar disorder	2.92e-05	0.0002	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—DRD1—bipolar disorder	2.91e-05	0.0002	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—HTR2C—bipolar disorder	2.91e-05	0.0002	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—POMC—bipolar disorder	2.9e-05	0.000199	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—DRD4—bipolar disorder	2.86e-05	0.000196	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ADM—bipolar disorder	2.86e-05	0.000196	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NTRK1—bipolar disorder	2.83e-05	0.000194	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TRPC3—bipolar disorder	2.82e-05	0.000194	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—DRD3—bipolar disorder	2.81e-05	0.000193	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PDE4B—bipolar disorder	2.78e-05	0.000191	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TSHB—bipolar disorder	2.78e-05	0.000191	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TACR1—bipolar disorder	2.78e-05	0.000191	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DRD5—bipolar disorder	2.77e-05	0.00019	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—S100B—bipolar disorder	2.75e-05	0.000189	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—IMPA2—bipolar disorder	2.74e-05	0.000188	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—HTR1A—bipolar disorder	2.73e-05	0.000188	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—DRD4—bipolar disorder	2.73e-05	0.000188	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RGS4—bipolar disorder	2.71e-05	0.000186	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ADM—bipolar disorder	2.69e-05	0.000185	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—TAC1—bipolar disorder	2.69e-05	0.000185	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—ADCY2—bipolar disorder	2.69e-05	0.000185	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—DRD2—bipolar disorder	2.66e-05	0.000183	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—HTR2C—bipolar disorder	2.64e-05	0.000181	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—DRD1—bipolar disorder	2.64e-05	0.000181	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PDE4B—bipolar disorder	2.62e-05	0.00018	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TSHB—bipolar disorder	2.62e-05	0.00018	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TACR1—bipolar disorder	2.62e-05	0.00018	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NRG1—bipolar disorder	2.57e-05	0.000177	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—ADCY2—bipolar disorder	2.57e-05	0.000177	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—DRD3—bipolar disorder	2.56e-05	0.000176	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—DRD2—bipolar disorder	2.55e-05	0.000175	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—HTR2A—bipolar disorder	2.54e-05	0.000175	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—POMC—bipolar disorder	2.52e-05	0.000173	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—DRD4—bipolar disorder	2.48e-05	0.00017	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NRG1—bipolar disorder	2.43e-05	0.000167	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TRPC3—bipolar disorder	2.42e-05	0.000166	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—HTR2A—bipolar disorder	2.4e-05	0.000165	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—ADCY2—bipolar disorder	2.34e-05	0.00016	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—HTR2A—bipolar disorder	2.32e-05	0.000159	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—DRD2—bipolar disorder	2.31e-05	0.000159	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—HTR2A—bipolar disorder	2.31e-05	0.000159	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ADM—bipolar disorder	2.3e-05	0.000158	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HTR1A—bipolar disorder	2.3e-05	0.000158	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TAC1—bipolar disorder	2.27e-05	0.000156	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TSHB—bipolar disorder	2.25e-05	0.000154	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PDE4B—bipolar disorder	2.25e-05	0.000154	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TACR1—bipolar disorder	2.25e-05	0.000154	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HTR2C—bipolar disorder	2.23e-05	0.000153	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—DRD1—bipolar disorder	2.23e-05	0.000153	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—HTR2A—bipolar disorder	2.19e-05	0.00015	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—HTR2A—bipolar disorder	2.18e-05	0.00015	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HTR1A—bipolar disorder	2.17e-05	0.000149	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NTRK2—bipolar disorder	2.16e-05	0.000149	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—DRD3—bipolar disorder	2.16e-05	0.000148	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—GSK3A—bipolar disorder	2.15e-05	0.000147	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TAC1—bipolar disorder	2.14e-05	0.000147	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HTR2C—bipolar disorder	2.1e-05	0.000144	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TRPC3—bipolar disorder	2.1e-05	0.000144	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—DRD4—bipolar disorder	2.09e-05	0.000144	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—POMC—bipolar disorder	2.07e-05	0.000142	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—HTR2A—bipolar disorder	2.05e-05	0.000141	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NTRK2—bipolar disorder	2.04e-05	0.00014	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—DRD3—bipolar disorder	2.03e-05	0.00014	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—POMC—bipolar disorder	2.03e-05	0.00014	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—GSK3A—bipolar disorder	2.02e-05	0.000139	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ADM—bipolar disorder	2e-05	0.000137	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—DRD4—bipolar disorder	1.97e-05	0.000135	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ADCY2—bipolar disorder	1.97e-05	0.000135	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TCF7L2—bipolar disorder	1.96e-05	0.000135	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PDE4B—bipolar disorder	1.95e-05	0.000134	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TSHB—bipolar disorder	1.95e-05	0.000134	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TACR1—bipolar disorder	1.95e-05	0.000134	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—DRD2—bipolar disorder	1.95e-05	0.000134	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—POMC—bipolar disorder	1.92e-05	0.000132	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—GSK3B—bipolar disorder	1.87e-05	0.000128	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—HTR2A—bipolar disorder	1.86e-05	0.000128	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HTR1A—bipolar disorder	1.86e-05	0.000128	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ADCY2—bipolar disorder	1.86e-05	0.000128	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—POMC—bipolar disorder	1.85e-05	0.000127	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—IMPA1—bipolar disorder	1.85e-05	0.000127	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TCF7L2—bipolar disorder	1.85e-05	0.000127	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—POMC—bipolar disorder	1.85e-05	0.000127	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—INS—bipolar disorder	1.84e-05	0.000127	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—DRD2—bipolar disorder	1.84e-05	0.000126	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TAC1—bipolar disorder	1.83e-05	0.000126	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—DRD1—bipolar disorder	1.8e-05	0.000123	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NTRK1—bipolar disorder	1.76e-05	0.000121	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—GSK3B—bipolar disorder	1.76e-05	0.000121	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—POMC—bipolar disorder	1.75e-05	0.00012	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NTRK2—bipolar disorder	1.75e-05	0.00012	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—POMC—bipolar disorder	1.74e-05	0.00012	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—INS—bipolar disorder	1.74e-05	0.000119	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—DRD3—bipolar disorder	1.74e-05	0.000119	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GSK3A—bipolar disorder	1.73e-05	0.000119	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—S100B—bipolar disorder	1.72e-05	0.000118	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—DRD4—bipolar disorder	1.69e-05	0.000116	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NTRK1—bipolar disorder	1.66e-05	0.000114	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—POMC—bipolar disorder	1.64e-05	0.000113	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—S100B—bipolar disorder	1.62e-05	0.000111	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HTR1A—bipolar disorder	1.61e-05	0.000111	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TAC1—bipolar disorder	1.59e-05	0.000109	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ADCY2—bipolar disorder	1.59e-05	0.000109	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TCF7L2—bipolar disorder	1.58e-05	0.000109	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—NDUFV2—bipolar disorder	1.57e-05	0.000108	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—DRD2—bipolar disorder	1.57e-05	0.000108	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HTR2C—bipolar disorder	1.56e-05	0.000107	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DRD1—bipolar disorder	1.56e-05	0.000107	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—AKR1C4—bipolar disorder	1.52e-05	0.000105	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NTRK2—bipolar disorder	1.52e-05	0.000104	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NRG1—bipolar disorder	1.51e-05	0.000104	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DRD3—bipolar disorder	1.51e-05	0.000104	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GSK3A—bipolar disorder	1.5e-05	0.000103	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—POMC—bipolar disorder	1.49e-05	0.000102	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DRD4—bipolar disorder	1.47e-05	0.000101	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NRG1—bipolar disorder	1.43e-05	9.8e-05	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—POMC—bipolar disorder	1.42e-05	9.78e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NTRK1—bipolar disorder	1.42e-05	9.78e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—S100B—bipolar disorder	1.38e-05	9.5e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ADCY2—bipolar disorder	1.38e-05	9.47e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TCF7L2—bipolar disorder	1.37e-05	9.44e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—NR1D1—bipolar disorder	1.37e-05	9.4e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DRD2—bipolar disorder	1.37e-05	9.38e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HTR2A—bipolar disorder	1.37e-05	9.37e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—NCAN—bipolar disorder	1.31e-05	8.99e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—POMC—bipolar disorder	1.29e-05	8.88e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HTR2A—bipolar disorder	1.29e-05	8.84e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SLC5A3—bipolar disorder	1.28e-05	8.81e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NTRK1—bipolar disorder	1.24e-05	8.49e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NRG1—bipolar disorder	1.22e-05	8.39e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—S100B—bipolar disorder	1.2e-05	8.25e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HTR2A—bipolar disorder	1.1e-05	7.56e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—GSK3B—bipolar disorder	1.1e-05	7.55e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—POMC—bipolar disorder	1.09e-05	7.49e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—INS—bipolar disorder	1.08e-05	7.45e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NRG1—bipolar disorder	1.06e-05	7.28e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—GSK3B—bipolar disorder	1.04e-05	7.12e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—POMC—bipolar disorder	1.03e-05	7.06e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—INS—bipolar disorder	1.02e-05	7.02e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CLOCK—bipolar disorder	9.28e-06	6.37e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—TSHB—bipolar disorder	9.04e-06	6.21e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—TPH2—bipolar disorder	9.04e-06	6.21e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CACNB2—bipolar disorder	9.04e-06	6.21e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—DPYD—bipolar disorder	8.89e-06	6.11e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GSK3B—bipolar disorder	8.87e-06	6.09e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—POMC—bipolar disorder	8.8e-06	6.04e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—INS—bipolar disorder	8.75e-06	6.01e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CACNA1C—bipolar disorder	8.27e-06	5.68e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	8.06e-06	5.53e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GSK3B—bipolar disorder	7.7e-06	5.29e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—POMC—bipolar disorder	7.64e-06	5.24e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—INS—bipolar disorder	7.6e-06	5.22e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SNAP25—bipolar disorder	7.23e-06	4.96e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ADCY2—bipolar disorder	6.4e-06	4.39e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—COMT—bipolar disorder	5.48e-06	3.76e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—MAOA—bipolar disorder	5.44e-06	3.73e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—MTHFR—bipolar disorder	4.43e-06	3.04e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—POMC—bipolar disorder	3.54e-06	2.43e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—INS—bipolar disorder	3.52e-06	2.42e-05	CbGpPWpGaD
